Sfoglia per Afferenza ROMA - Dipartimento di Scienze cardiovascolari e pneumologiche
A new device to treat mitral valve regurgitation: a proof of concept in bench test study
2021 Chiariello, Giovanni Alfonso; Kuci, S.; Saitto, G.; Massetti, Massimo; Alfieri, O.; Zeitani, J.
New era of management concept on pulmonary fibrosis with revisiting framework of interstitial lung diseases
2020 Azuma, A.; Richeldi, Luca
The new frontiers in prevention: From sports cardiology to spaceflight, and back to earth with cardiovascular disease and cancer
2021 Crea, Filippo
The new frontiers in valvular heart disease: From artificial intelligence to new pharmacological targets in aortic stenosis
2021 Crea, Filippo
The new frontiers of imaging from echocardiography to positron emission tomography, and also what happened in the last year in digital health and imaging
2021 Crea, Filippo
New guidelines on adult congenital heart disease, the fantastic four in the treatment of heart failure, and also what happened in the last year in heart failure and valvular heart disease
2021 Crea, Filippo
A new initiative of the European Heart Journal: the Desmond Julian Award
2021 Crea, Filippo; Braunwald, E.
New light on a forgotten disease: vasospastic angina
2011 Lanza, Gaetano Antonio; Crea, Filippo
A New Mini-Invasive Approach for a Catastrophic Disease: Staged Endovascular and Endoscopic Treatment of Aorto-Esophageal Fistulas
2022 Donato, Federica; Boskoski, Ivo; Vincenzoni, Claudio; Montanari, Francesca; Tinelli, Giovanni; Donati, Tommaso; Tshomba, Yamume
New modalities of ultrasound-based intima-media thickness, arterial stiffness and non-coronary vascular calcifications detection to assess cardiovascular risk
2015 Flore, Roberto Antonio; Ponziani, Francesca Romana; Tinelli, Giovanni; Arena, Vincenzo; Fonnesu, Claudia; Nesci, Antonio; Santoro, Luca; Tondi, Paolo; Santoliquido, Angelo
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper
2012 De Caterina, R; Husted, S; Wallentin, L; Andreotti, Felicita; Arnesen, H; Bachmann, F; Baigent, C; Huber, K; Jespersen, J; Kristensen, Sd; Lip, Gyh; Morais, J; Rasmussen, Lh; Siegbahn, A; Verheugt, Fwa; Weitz, Ji
New prediction tools and treatment for ACS patients with plaque erosion
2021 Vergallo, Rocco; Jang, I. -K.; Crea, Filippo
The new SCORE2 risk prediction algorithms and the growing challenge of risk factors not captured by traditional risk scores
2021 Crea, Filippo
New strategies for the management of no-reflow after primary percutaneous coronary intervention
2011 Niccoli, Giampaolo; Cosentino, Nicola; Spaziani, Cristina; Minelli, S; Fracassi, Federica; Crea, Filippo
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
2021 Cottin, Vincent; Richeldi, Luca; Rosas, Ivan; Otaola, Maria; Song, Jin Woo; Tomassetti, Sara; Wijsenbeek, Marlies; Schmitz, Manuela; Coeck, Carl; Stowasser, Susanne; Schlenker-Herceg, Rozsa; Kolb, Martin
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS®trials
2016 Richeldi, Luca; Cottin, Vincent; du Bois, Roland M.; Selman, Moisés; Kimura, Toshio; Bailes, Zelie; Schlenker-Herceg, Rozsa; Stowasser, Susanne; Brown, Kevin K.
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
2020 Wells, A. U.; Flaherty, K. R.; Brown, K. K.; Inoue, Y.; Devaraj, A.; Richeldi, Luca; Moua, T.; Crestani, B.; Wuyts, W. A.; Stowasser, S.; Quaresma, M.; Goeldner, R. -G.; Schlenker-Herceg, R.; Kolb, M.; Abe, S.; Aburto, M.; Acosta, O.; Andrews, C.; Antin-Ozerkis, D.; Arce, G.; Arias, M.; Avdeev, S.; Barczyk, A.; Bascom, R.; Bazdyrev, E.; Beirne, P.; Belloli, E.; Bergna, M. A.; Bergot, E.; Bhatt, N.; Blaas, S.; Bondue, B.; Bonella, F.; Britt, E.; Buch, K.; Burk, J.; Cai, H.; Cantin, A.; Castillo Villegas, D. M.; Cazaux, A.; Cerri, S.; Chaaban, S.; Chaudhuri, N.; Cottin, V.; Crestani, B.; Criner, G.; Dahlqvist, C.; Danoff, S.; Dematte D'Amico, J.; Dilling, D.; Elias, P.; Ettinger, N.; Falk, J.; Fernandez Perez, E. R.; Gamez-Dubuis, A.; Giessel, G.; Gifford, A.; Glassberg, M.; Glazer, C.; Golden, J.; Gomez Carrera, L.; Guiot, J.; Hallowell, R.; Hayashi, H.; Hetzel, J.; Hirani, N.; Homik, L.; Hope-Gill, B.; Hotchkin, D.; Ichikado, K.; Ilkovich, M.; Inoue, Y.; Izumi, S.; Jassem, E.; Jones, L.; Jouneau, S.; Kaner, R.; Kang, J.; Kawamura, T.; Kessler, R.; Kim, Y.; Kishi, K.; Kitamura, H.; Kolb, M.; Kondoh, Y.; Kono, C.; Koschel, D.; Kreuter, M.; Kulkarni, T.; Kus, J.; Lebargy, F.; Leon Jimenez, A.; Luo, Q.; Mageto, Y.; Maher, T. M.; Makino, S.; Marchand-Adam, S.; Marquette, C.; Martinez, Sara; Martinez, M.; Maturana Rozas, R.; Miyazaki, Y.; Moiseev, S.; Molina-Molina, M.; Malcolm, Joan Morrison; Morrow, L.; Moua, T.; Nambiar, A.; Nishioka, Y.; Nunes, H.; Okamoto, M.; Oldham, J.; Otaola, M.; Padilla, M.; Park, J. S.; Patel, N.; Pesci, Riccardo; Piotrowski, W.; Pitts, L.; Poonyagariyagorn, H.; Prasse, A.; Quadrelli, S.; Randerath, W.; Refini, R.; Reynaud-Gaubert, M.; Riviere, F.; Rodriguez Portal, J. A.; Rosas, I.; Rossman, M.; Safdar, Z.; Saito, T.; Sakamoto, N.; Salinas Fenero, M.; Sauleda, J.; Schmidt, S.; Scholand, M. B.; Schwartz, M.; Shapera, S.; Shlobin, O.; Sigal, B.; Silva Orellana, A.; Skowasch, D.; Song, J. W.; Stieglitz, S.; Stone, H.; Strek, M.; Suda, T.; Sugiura, H.; Takahashi, H.; Takaya, H.; Takeuchi, T.; Thavarajah, K.; Tolle, L.; Tomassetti, S.; Tomii, K.; Valenzuela, C.; Vancheri, C.; Varone, Francesco; Veeraraghavan, S.; Villar, A.; Weigt, S.; Wemeau, L.; Wuyts, W.; Xu, Z.; Yakusevich, V.; Yamada, Y.; Yamauchi, H.; Ziora, D.
Nintedanib in progressive fibrosing interstitial lung diseases
2019 Flaherty, K. R.; Wells, A. U.; Cottin, V.; Devaraj, A.; Walsh, S. L. F.; Inoue, Y.; Richeldi, Luca; Kolb, M.; Tetzlaff, K.; Stowasser, S.; Coeck, C.; Clerisme-Beaty, E.; Rosenstock, B.; Quaresma, M.; Haeufel, T.; Goeldner, R. -G.; Schlenker-Herceg, R.; Brown, K. K.
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial
2021 Flaherty, Kevin R; Wells, Athol U; Cottin, Vincent; Devaraj, Anand; Inoue, Yoshikazu; Richeldi, Luca; Walsh, Simon L F; Kolb, Martin; Koschel, Dirk; Moua, Teng; Stowasser, Susanne; Goeldner, Rainer-Georg; Schlenker-Herceg, Rozsa; Brown, Kevin K
Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis
2018 Kolb, M.; Raghu, G.; Wells, A. U.; Behr, J.; Richeldi, Luca; Schinzel, B.; Quaresma, M.; Stowasser, S.; Martinez, F. J.
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2021 | A new device to treat mitral valve regurgitation: a proof of concept in bench test study | Chiariello, Giovanni Alfonso; Kuci, S.; Saitto, G.; Massetti, Massimo; Alfieri, O.; Zeitani, J. | |
| 1-gen-2020 | New era of management concept on pulmonary fibrosis with revisiting framework of interstitial lung diseases | Azuma, A.; Richeldi, Luca | |
| 1-gen-2021 | The new frontiers in prevention: From sports cardiology to spaceflight, and back to earth with cardiovascular disease and cancer | Crea, Filippo | |
| 1-gen-2021 | The new frontiers in valvular heart disease: From artificial intelligence to new pharmacological targets in aortic stenosis | Crea, Filippo | |
| 1-gen-2021 | The new frontiers of imaging from echocardiography to positron emission tomography, and also what happened in the last year in digital health and imaging | Crea, Filippo | |
| 1-gen-2021 | New guidelines on adult congenital heart disease, the fantastic four in the treatment of heart failure, and also what happened in the last year in heart failure and valvular heart disease | Crea, Filippo | |
| 1-gen-2021 | A new initiative of the European Heart Journal: the Desmond Julian Award | Crea, Filippo; Braunwald, E. | |
| 1-gen-2011 | New light on a forgotten disease: vasospastic angina | Lanza, Gaetano Antonio; Crea, Filippo | |
| 1-gen-2022 | A New Mini-Invasive Approach for a Catastrophic Disease: Staged Endovascular and Endoscopic Treatment of Aorto-Esophageal Fistulas | Donato, Federica; Boskoski, Ivo; Vincenzoni, Claudio; Montanari, Francesca; Tinelli, Giovanni; Donati, Tommaso; Tshomba, Yamume | |
| 1-gen-2015 | New modalities of ultrasound-based intima-media thickness, arterial stiffness and non-coronary vascular calcifications detection to assess cardiovascular risk | Flore, Roberto Antonio; Ponziani, Francesca Romana; Tinelli, Giovanni; Arena, Vincenzo; Fonnesu, Claudia; Nesci, Antonio; Santoro, Luca; Tondi, Paolo; Santoliquido, Angelo | |
| 1-gen-2012 | New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper | De Caterina, R; Husted, S; Wallentin, L; Andreotti, Felicita; Arnesen, H; Bachmann, F; Baigent, C; Huber, K; Jespersen, J; Kristensen, Sd; Lip, Gyh; Morais, J; Rasmussen, Lh; Siegbahn, A; Verheugt, Fwa; Weitz, Ji | |
| 1-gen-2021 | New prediction tools and treatment for ACS patients with plaque erosion | Vergallo, Rocco; Jang, I. -K.; Crea, Filippo | |
| 1-gen-2021 | The new SCORE2 risk prediction algorithms and the growing challenge of risk factors not captured by traditional risk scores | Crea, Filippo | |
| 1-gen-2011 | New strategies for the management of no-reflow after primary percutaneous coronary intervention | Niccoli, Giampaolo; Cosentino, Nicola; Spaziani, Cristina; Minelli, S; Fracassi, Federica; Crea, Filippo | |
| 1-gen-2021 | Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases | Cottin, Vincent; Richeldi, Luca; Rosas, Ivan; Otaola, Maria; Song, Jin Woo; Tomassetti, Sara; Wijsenbeek, Marlies; Schmitz, Manuela; Coeck, Carl; Stowasser, Susanne; Schlenker-Herceg, Rozsa; Kolb, Martin | |
| 1-gen-2016 | Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS®trials | Richeldi, Luca; Cottin, Vincent; du Bois, Roland M.; Selman, Moisés; Kimura, Toshio; Bailes, Zelie; Schlenker-Herceg, Rozsa; Stowasser, Susanne; Brown, Kevin K. | |
| 1-gen-2020 | Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial | Wells, A. U.; Flaherty, K. R.; Brown, K. K.; Inoue, Y.; Devaraj, A.; Richeldi, Luca; Moua, T.; Crestani, B.; Wuyts, W. A.; Stowasser, S.; Quaresma, M.; Goeldner, R. -G.; Schlenker-Herceg, R.; Kolb, M.; Abe, S.; Aburto, M.; Acosta, O.; Andrews, C.; Antin-Ozerkis, D.; Arce, G.; Arias, M.; Avdeev, S.; Barczyk, A.; Bascom, R.; Bazdyrev, E.; Beirne, P.; Belloli, E.; Bergna, M. A.; Bergot, E.; Bhatt, N.; Blaas, S.; Bondue, B.; Bonella, F.; Britt, E.; Buch, K.; Burk, J.; Cai, H.; Cantin, A.; Castillo Villegas, D. M.; Cazaux, A.; Cerri, S.; Chaaban, S.; Chaudhuri, N.; Cottin, V.; Crestani, B.; Criner, G.; Dahlqvist, C.; Danoff, S.; Dematte D'Amico, J.; Dilling, D.; Elias, P.; Ettinger, N.; Falk, J.; Fernandez Perez, E. R.; Gamez-Dubuis, A.; Giessel, G.; Gifford, A.; Glassberg, M.; Glazer, C.; Golden, J.; Gomez Carrera, L.; Guiot, J.; Hallowell, R.; Hayashi, H.; Hetzel, J.; Hirani, N.; Homik, L.; Hope-Gill, B.; Hotchkin, D.; Ichikado, K.; Ilkovich, M.; Inoue, Y.; Izumi, S.; Jassem, E.; Jones, L.; Jouneau, S.; Kaner, R.; Kang, J.; Kawamura, T.; Kessler, R.; Kim, Y.; Kishi, K.; Kitamura, H.; Kolb, M.; Kondoh, Y.; Kono, C.; Koschel, D.; Kreuter, M.; Kulkarni, T.; Kus, J.; Lebargy, F.; Leon Jimenez, A.; Luo, Q.; Mageto, Y.; Maher, T. M.; Makino, S.; Marchand-Adam, S.; Marquette, C.; Martinez, Sara; Martinez, M.; Maturana Rozas, R.; Miyazaki, Y.; Moiseev, S.; Molina-Molina, M.; Malcolm, Joan Morrison; Morrow, L.; Moua, T.; Nambiar, A.; Nishioka, Y.; Nunes, H.; Okamoto, M.; Oldham, J.; Otaola, M.; Padilla, M.; Park, J. S.; Patel, N.; Pesci, Riccardo; Piotrowski, W.; Pitts, L.; Poonyagariyagorn, H.; Prasse, A.; Quadrelli, S.; Randerath, W.; Refini, R.; Reynaud-Gaubert, M.; Riviere, F.; Rodriguez Portal, J. A.; Rosas, I.; Rossman, M.; Safdar, Z.; Saito, T.; Sakamoto, N.; Salinas Fenero, M.; Sauleda, J.; Schmidt, S.; Scholand, M. B.; Schwartz, M.; Shapera, S.; Shlobin, O.; Sigal, B.; Silva Orellana, A.; Skowasch, D.; Song, J. W.; Stieglitz, S.; Stone, H.; Strek, M.; Suda, T.; Sugiura, H.; Takahashi, H.; Takaya, H.; Takeuchi, T.; Thavarajah, K.; Tolle, L.; Tomassetti, S.; Tomii, K.; Valenzuela, C.; Vancheri, C.; Varone, Francesco; Veeraraghavan, S.; Villar, A.; Weigt, S.; Wemeau, L.; Wuyts, W.; Xu, Z.; Yakusevich, V.; Yamada, Y.; Yamauchi, H.; Ziora, D. | |
| 1-gen-2019 | Nintedanib in progressive fibrosing interstitial lung diseases | Flaherty, K. R.; Wells, A. U.; Cottin, V.; Devaraj, A.; Walsh, S. L. F.; Inoue, Y.; Richeldi, Luca; Kolb, M.; Tetzlaff, K.; Stowasser, S.; Coeck, C.; Clerisme-Beaty, E.; Rosenstock, B.; Quaresma, M.; Haeufel, T.; Goeldner, R. -G.; Schlenker-Herceg, R.; Brown, K. K. | |
| 1-gen-2021 | Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial | Flaherty, Kevin R; Wells, Athol U; Cottin, Vincent; Devaraj, Anand; Inoue, Yoshikazu; Richeldi, Luca; Walsh, Simon L F; Kolb, Martin; Koschel, Dirk; Moua, Teng; Stowasser, Susanne; Goeldner, Rainer-Georg; Schlenker-Herceg, Rozsa; Brown, Kevin K | |
| 1-gen-2018 | Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis | Kolb, M.; Raghu, G.; Wells, A. U.; Behr, J.; Richeldi, Luca; Schinzel, B.; Quaresma, M.; Stowasser, S.; Martinez, F. J. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile